Acrivon Therapeutics, Inc. (ACRV)
1.52
+0.06
(+4.11%)
USD |
NASDAQ |
Apr 02, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
Acrivon Therapeutics Total Assets (Quarterly) : 130.82M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aclarion, Inc. | 25.50M |
| Incyte Corp. | 6.971B |
| Karyopharm Therapeutics, Inc. | 117.46M |
| Erasca, Inc. | 407.46M |
| Humacyte, Inc. | 116.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.30M |
| Shareholders Equity (Quarterly) | 112.52M |
| Debt to Equity Ratio | 0.0241 |
| Current Ratio | 7.689 |
| Net Debt Paydown Yield | 0.34% |